Spontaneous Breathing Trial in ICU
Conditions
Brief summary
Weaning from mechanical ventilation (MV) accounts for a significant portion of the total MV duration, and failure to extubate or delayed extubation increases complications (particularly Ventilator-Associated Pneumonia (VAP)) and mortality. Standard tests (T-piece, Spontaneous Ventilation with Inspiratory Assistance (SV-IA)) have not demonstrated clear superiority, and the T-piece is still widely used despite its limitations. High-flow oxygen (HFO) may reduce ventilatory work and facilitate secretion clearance; however, there is a lack of physiological data in humans with an endotracheal tube in place. This study aims to address this gap prior to a subsequent clinical evaluation. An experimental, prospective, single-center, 3-period crossover study with randomized sequence order and single-blind design (primary endpoint assessment and statistical analysis were conducted in a blinded manner).
Interventions
The endotracheal tube will be disconnected from the ventilator, and a T-piece (Teleflex, Trach-Vent +®) with oxygen delivery
The endotracheal tube will be connected to the pneumotachograph. The ventilator settings will be adjusted as follows: VS mode, inspiratory support at 7 cmH₂O, PEEP at 0 cmH₂O.
The endotracheal tube will be disconnected from the ventilator, and an OHD delivery device normally used for tracheostomies (Fisher \& Paykel, Optiflow+®) will be connected to the pneumotachograph. The OHD flow rate will be set to 50 L/min. A Monnal T60 ventilator (Air Liquide Healthcare) will be used for OHD administration.
Sponsors
Study design
Eligibility
Inclusion criteria
* Adult patient, of legal age * On invasive mechanical ventilation for more than 48 hours * With at least one criterion indicating a high risk of extubation failure: * Age \> 65 years * Chronic respiratory disease * Chronic cardiac disease * Capable of undergoing a mechanical ventilation weaning test ("weaning criterion"): * Respiratory rate \< 35 bpm * Adequate oxygenation: * SpO₂ ≥ 90% with FiO₂ ≤ 40% and PEEP ≤ 8 cm H₂O * Or PaO₂/FiO₂ ≥ 150 with PEEP ≤ 8 cm H₂O * Effective cough * Patient is alert (RASS score -2 to +1), without sedation * Hemodynamically stable or on the minimum effective dose * Patient has an invasive arterial pressure catheter for arterial blood sampling * Informed consent signed by a family member * Patient is enrolled in or eligible for a social security program
Exclusion criteria
* Resuscitation-associated neuromyopathy * History of neuromuscular disease * Admission for a neurological condition * Subjects currently excluded from another study, * Persons referred to in Articles L1121-5 through L1121-8 of the CSP (corresponding to all protected persons: pregnant women, women in labor, breastfeeding mothers, persons deprived of liberty by judicial or administrative decision, persons receiving psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1 who are not covered by the provisions of Article L. 1121-8, persons admitted to a health or social care facility for purposes other than research, minors, and persons subject to a legal protection order or unable to give informed consent). * Staff members who report to the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Respiratory work during the weaning test, defined as the energy expended to inhale and exhale a respiratory gas, measured in joules per liter per minute. | 190 min |
Secondary
| Measure | Time frame |
|---|---|
| Tidal Volume | 190 min |
| Total Positive End-Expiratory Pressure | 190 min |
| Respiratory Rate | 190 min |
| minute ventilation | 190 min |
| Ratio Respiratory rate/ Tidal volume | 190 min |
| product pressure time | 190 min |
| Occlusion pressure (or P 0.1) | 190 min |
| Percentage of success on the weaning test (predefined criteria) | 190 min |